GENERATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR THE HUMAN NEU ONCOGENE PRODUCT, P185
- 1 May 1989
- journal article
- research article
- Vol. 4 (5) , 543-548
Abstract
A series of monoclonal antibodies specific for the extracellular domain of the human neu gene product (p185) have been produced. The generation of these monoclonal antibodies, and their biochemical and immunological characterization is described. The immunization protocol utilized a series of injections of NIH3T3 cells, cyclophosphamide, and a neu transfected NIH3T3 cell line (designated 18-3-7) which expressed the full length human neu-encoded protein. This immunization regimen induced an immune response to the extracellular portion of p185 on the 18-3-7 cells. A panel of ten hybridomas were identified which secreted monoclonal antibodies with a variety of epitope specificities, and reacted with p185 in a number of different experimental formats. As the neu gene product has been associated with human breast cancers a series of monoclonal antibodies such as these could prove useful in the diagnosis, prognosis and/or treatment of these human malignancies.This publication has 12 references indexed in Scilit:
- ASSOCIATION OF MULTIPLE COPIES OF THE C-ERBB-2 ONCOGENE WITH SPREAD OF BREAST-CANCER1987
- Expression of the c‐erbB‐2 protein in normal and transformed cellsInternational Journal of Cancer, 1987
- Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease.Journal of Clinical Oncology, 1987
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.The EMBO Journal, 1987
- ALTERATIONS TO EITHER C-ERB-2 (NEU)-PROTO-ONCOGENE OR C-MYC-PROTO-ONCOGENE IN BREAST CARCINOMAS CORRELATE WITH POOR SHORT-TERM PROGNOSIS1987
- Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.Proceedings of the National Academy of Sciences, 1986
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984
- An Improved Technique for Obtaining Enhanced Infectivity with Herpes Simplex Virus Type 1 DNAJournal of General Virology, 1976